CCL3 and chronic myelogenous leukemia, BCR-ABL1 positive: MIP1α is considered to be crucial for modulating inflammation responses (25, 26), and the expression of MIP1α was increased in patients with chronic myeloid leukemia (27) and acute pancreatitis (28).